These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 239180)

  • 21. Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration.
    Cunningham JL; Evans DA
    Eur J Clin Pharmacol; 1974 Aug; 7(5):387-91. PubMed ID: 4417891
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man.
    Hunter J; Burnham WR; Chasseaud LF; Down W
    Biochem Pharmacol; 1974 Sep; 23(17):2480-3. PubMed ID: 4429583
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary D-glucaric acid. An index of heparin microsomal enzyme activity in human females.
    Fahim MS; Hall DG; Fahim Z
    Am J Obstet Gynecol; 1969 Sep; 105(1):124-6. PubMed ID: 5805242
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. V. Stimulatory effect of diphenylhydantoin and phenobarbital on the D-glucaric acid synthesis in man.
    Okada M; Matsui M; Kaizu T; Abe F
    Chem Pharm Bull (Tokyo); 1969 Dec; 17(12):2625-8. PubMed ID: 5373168
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of two methods for quantifying D-glucaric acid.
    Steinberg KK; Needham LL
    J Anal Toxicol; 1986; 10(4):139-41. PubMed ID: 3747452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pheneturide, a more potent liver enzyme inducer in man than phenobarbitone?
    Latham AN; Richens A
    Br J Pharmacol; 1973 Mar; 47(3):615P. PubMed ID: 4730837
    [No Abstract]   [Full Text] [Related]  

  • 27. [Circadian rhythms of lithogenic and inhibitory substances in the urine].
    Ebisuno S; Morimoto S; Yasukawa S; Yoshida T; Fukatani T; Minakata S; Uehara M; Ohkawa T
    Hinyokika Kiyo; 1986 May; 32(5):667-71. PubMed ID: 3751794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary D-glucaric acid excretion during rifampicin/isoniazid and anticonvulsant enzyme induction.
    Perry W; Stamp TC
    Clin Pharmacol Ther; 1984 May; 35(5):710-5. PubMed ID: 6143635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the low-pH enzymatic assay of urinary D-glucaric acid, and its use as a marker of enzyme induction in exocrine pancreatic disease.
    Sandle LN; Braganza JM
    Clin Chim Acta; 1987 Feb; 162(3):245-56. PubMed ID: 3568402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Change of urinary pH in relation to the ovulatory phase].
    Musso G; Nizza M; Fariello R
    Minerva Ginecol; 1968 Feb; 20(4):384-92. PubMed ID: 5738738
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum gamma-glutamyl-transpeptidase and urinary excretion of D-glucaric acid in epileptic patients treated with anticonvulsants].
    Smirne S; Ideo G; Colombo M; Lanzi GL
    Riv Neurol; 1974; 44(4):234-8. PubMed ID: 4155805
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention.
    Walaszek Z; Szemraj J; Narog M; Adams AK; Kilgore J; Sherman U; Hanausek M
    Cancer Detect Prev; 1997; 21(2):178-90. PubMed ID: 9101079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of urinary D-glucaric acid excretion in workers exposed to butyl glycol.
    Collinot JP; Collinot JC; Deschamps F; Decolin D; Siest G; Galteau MM
    J Toxicol Environ Health; 1996 Jul; 48(4):349-58. PubMed ID: 8691506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of beta-glucuronidase in human urine by ascorbic acid.
    Young JC; Kenyon EM; Calabrese EJ
    Hum Exp Toxicol; 1990 May; 9(3):165-70. PubMed ID: 2375883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antiepileptic drug monotherapy on urinary pH in children and young adults.
    Go T
    Childs Nerv Syst; 2006 Jan; 22(1):56-9. PubMed ID: 15909204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of gastrointestinal beta-glucuronidase by poly(vinylbenzyl D-glucaro(1,4)lactonate). Part 2. Poly(vinylbenzyl D-glucaro(1,4) lactonate) in vitro inhibition studies.
    Sacco C; Calabrese EJ
    Hum Exp Toxicol; 1994 Nov; 13(11):759-63. PubMed ID: 7857695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The occurrence of adipic and suberic acid in urine from ketotic patients.
    Pettersen JE; Jellum E; Eldjarn L
    Clin Chim Acta; 1972 Apr; 38(1):17-24. PubMed ID: 5031780
    [No Abstract]   [Full Text] [Related]  

  • 39. An enzymatic determination of D-glucaric acid by conversion to pyruvate.
    Marsh CA
    Anal Biochem; 1985 Mar; 145(2):266-72. PubMed ID: 3893213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical studies on the recurrence of urolithiasis (5). Diurnal variation in urinary pH and stone compositions].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Oct; 34(10):1711-5. PubMed ID: 3245520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.